Medications
Investigation questions motives behind post-marketing studies
An investigation published by the BMJ today raises concern about the motives behind post-marketing studies of new treatments for diabetes and calls for better regulation to ensure "a proper balance" between the commercial ...
Jun 12, 2012
0
0
